About
A motivated self-starter with strong commercial focus and solution-driven work ethic.…
Activity
2K followers
-
Kevin Clayton reposted thisKevin Clayton reposted thisWe've worked with pharma sales teams through pilots, go-live, and long after. One thing is consistently true: the teams that get the most out of a new platform aren't always the ones with the best technology. They're the ones whose rollout was done right. Peer-led training, manager alignment, and the right post-launch support make the difference. In our latest article, we explore why most pharma AI deployments stall, and the change management principles behind the ones that deliver lasting adoption and ROI. Read the full article here: https://lnkd.in/escWBsTU
-
Kevin Clayton shared thisExcited to see the keynotes from Kate Gattuso Duffy, MBA & Sopheara Peoples! If you are planning to be at Veeva Summit, let me know, I would love to grab time with you! #veevasummit
-
Kevin Clayton shared thisThis has been a fantastic partnership with phenomenal early results for our clients!Kevin Clayton shared thisHighlighting a distinctive new AI-powered marketing solution for pharma brand teams: ODAIA provides the intelligence for targeting, messaging, and channel selection, while Pulse Health powers campaign automation. Together with ODAIA’s sales intelligence, this enables a first-of-its-kind coordination between marketing and sales deployments to drive what has been envisioned as "omnichannel" journeys. It will be interesting to see how capabilities like this transform the HCP experience.ODAIA and Pulse Health Partner to Help Pharma Convert More HCPs and Increase Prescription VolumeODAIA and Pulse Health Partner to Help Pharma Convert More HCPs and Increase Prescription Volume
-
Kevin Clayton reposted thisKevin Clayton reposted thisWe are officially accepting applications for the 2026 Galderma Internship Program! College students, this is an exciting opportunity to learn, grow, and launch your career. Our innovative, science-driven portfolio spans Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Guided by our purpose — Advancing dermatology for every skin story — we continue to lead the category as the pure-play dermatology company dedicated to meaningful solutions for physicians and patients. From marketing to sales to compliance and communications, we have internships open in Carlsbad, CA, Fort Worth, TX, Boston, MA, and Miami, FL. The eight-week internship begins June 22 and ends August 14. Scan the QR code above or click the link in the comments to explore roles near you! #AdvancingDermatology #WeAreGalderma
-
Kevin Clayton reposted thisGreat role!Kevin Clayton reposted thisWe’re hiring! Looking for a builder to lead Omnichannel + Next Best Action at Ascendis. If you’re excited about creating a scalable, AI‑enabled execution engine that empowers our rare disease commercial and medical teams, this is the role for you. Huge impact. Real ownership. And yes, you’ll have fun doing it.
-
Kevin Clayton reposted thisKevin Clayton reposted thisHi everyone, we continue to grow on our team. I've just posted a brand analytics role supporting our Hepatology portfolio. If you know any strong candidates or would like to apply, please do so and share! https://lnkd.in/eFYpSeJ7
-
Kevin Clayton reposted thisKevin Clayton reposted thisToday, ODAIA and Pulse Health announced a technology partnership that combines ODAIA’s Campaign Intelligence with Pulse Health’s Pulse Engagement Cloud. Together, the companies are driving automated and personalized healthcare professional (HCP) marketing campaigns for pharmaceutical brand teams. The companies shared that one joint customer has already deployed more than 600 campaigns using the joint solution, with 𝗺𝗲𝗮𝘀𝘂𝗿𝗮𝗯𝗹𝗲 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 𝗶𝗺𝗽𝗮𝗰𝘁 𝗼𝗯𝘀𝗲𝗿𝘃𝗲𝗱 𝘄𝗶𝘁𝗵𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗺𝗼𝗻𝘁𝗵 of activation. • ODAIA’s AI-engines evaluated the brand’s full target universe to identify the HCPs where outreach was predicted to drive prescribing impact and generated individualized, HCP-level campaign sequence recommendations using pre-approved content. • Those recommendations were activated through Pulse Health’s engagement platform, automating email execution and consolidating campaign and engagement data into a single workflow, with results flowing back into ODAIA to guide ongoing sequencing recommendations. 𝗧𝗵𝗲 𝗲𝗻𝗱 𝗿𝗲𝘀𝘂𝗹𝘁: marketing decisions informed by predictive intelligence, activated through existing engagement infrastructure, and measured by prescription impact rather than traditional marketing metrics. A big thank you to the Pulse Health team and to our customers' brand teams for working closely with us to show that true omnichannel execution and personalized HCP engagement are no longer just theoretical goals, but achievable operating models when intelligence and execution work together in market. https://lnkd.in/eQMkc_Wm
-
Kevin Clayton reposted thisKevin Clayton reposted thisA great opportunity to join our growing team. Feel free to reach out if you have questions or interest! posting: https://lnkd.in/eJD-DqjQOmni-Channel Marketing Director, Respiratory BiologicsOmni-Channel Marketing Director, Respiratory Biologics
-
Kevin Clayton reacted on thisKevin Clayton reacted on thisFIVE 💙 Five years ago, I said yes to Genentech. I’ll never forget how that day felt. After losing my dad and sister to cancer in the same year, I knew I wanted to pivot my career toward helping patients like them and their families. Looking back, that purpose has guided every role, every challenge, and every opportunity I’ve been fortunate enough to say yes to. The biggest lesson hasn’t been about titles or promotions. It’s that some of the best opportunities begin with staying curious, saying yes, and trusting you’ll figure it out. I’m grateful to be surrounded by people who never lose sight of who we’re doing this for. I feel incredibly fortunate to do work that gives patients and their families the chance for more time…something I would give anything to have had with my own. Five years at Genentech. Still driven by the same purpose.
-
Kevin Clayton liked thisKevin Clayton liked thisPatient care doesn't stop when someone leaves the clinic. And as device therapies, home infusion, and remote monitoring programs grow life sciences teams need tools to manage the full patient journey, wherever it leads. With Home Health now available for Agentforce Life Sciences, pharma and medtech organizations can: - Broadcast, schedule, and reschedule home visits with ease - Manage caregivers and coordinate home-based care - Execute each visit with contextual patient insights - Improve adherence and reduce treatment drop-off rates Better patient outcomes start with better tools. 💜 #AgentforceLifeSciences #HomeHealth #Summer26Release
-
Kevin Clayton reacted on thisKevin Clayton reacted on thisExcited to welcome Life Sciences leaders to our Global Summit: Future of Life Sciences in Munich and kick off the event with a special executive experience on Monday evening in collaboration with Deloitte Digital. Held at the incredible ESO Supernova Planetarium, we’re honored to welcome Dr. Mindy Howard, astronaut trainer and performance expert. Mindy’s journey is one of resilience, reinvention, and navigating uncertainty in pursuit of something bigger. And in many ways, it’s a reflection of the journey facing Life Sciences leaders today. As executives navigate some of the most significant technology investment decisions of our generation, from AI and data to entirely new operating models, the path forward is not always clear. The organizations that thrive will be those willing to explore beyond the familiar, challenge assumptions, and embrace new possibilities. Those that cling to the status quo risk being left behind. The future has never belonged to those waiting for certainty. The future belongs to explorers. 🧬 🚀 #FutureOfLifeSciences #Leadership #Innovation #Exploration #STEM #Salesforce #DeloitteDigital #Agentforce
-
Kevin Clayton liked thisKevin Clayton liked thisI’m proud to announce that I’ve been named a Novartis US Business Excellence Award winner. The best tool we gave our reps was their time back — spent where it matters most - with customers, for patients. This recognition reflects the power of teamwork, innovation, and a shared commitment to improving and extending people’s lives. Thank you to the incredible colleagues, partners, and leaders who made this possible. #Novartis #BusinessExcellence #CustomerEngagement #FieldCRM
-
Kevin Clayton reacted on thisKevin Clayton reacted on thisLast week, we were pleased to host the Seqirus Leadership Team (SQLT) in Summit for our quarterly meeting. One of the most meaningful parts of the week was the opportunity to highlight how teams across North America Commercial Operations and our business partners work together to serve our customers. The presentations on display throughout the office reflected the collaboration, planning and problem-solving that go into helping each customer prepare for flu season and support the vaccination needs of the communities they serve. Our work is not done in isolation, and our ability to help protect public health depends on strong partnerships with our customers year after year. For any of the broad variety of customers we serve, our shared goal is the same: helping more people get vaccinated and better protecting communities from the harmful complications of flu. Thank you to everyone who contributed and helped bring this to life. I especially want to recognize and thank Jack Coultry, Kevin Maize, Mark Faulkner, Ann H., Rachel Gevirtz Yocum, Taylor Desrosiers, Aimee Reed, Monica Fernand Demmers, Bob Miller, Brooke Pastore Cardoso, Abigail Sporer, Christopher McDougal, Andrew Rennekamp, PhD and Amy Walker for leading the presentations, as well as Lillian Raiski and John Reilly for helping make the week a success.
-
Kevin Clayton liked thisKevin Clayton liked thisHiring on my team at Bayer! I may be biased since this is the role where I started, but it was one of the most fun and impactful experiences of my career. You get to work with a wildly talented team (👋 DSPO) and a ridiculously smart product squad (👋 WHC team). We’re growing like crazy, continuing to build Bayer’s competitive edge and doing it in a culture you won’t find anywhere else. https://lnkd.in/e296Zm-fSenior Director, Digital Strategy & Activation - Women's HealthcareSenior Director, Digital Strategy & Activation - Women's Healthcare
-
Kevin Clayton reacted on thisKevin Clayton reacted on thisFood is medicine. In the US, it is also, increasingly, something a doctor can prescribe. New piece on the movement trying to put good food on the same reimbursement line as a drug
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Volunteer Experience
-
Assistant Coach
Parsippany PAL Football
- 2 years 4 months
Health
Recommendations received
1 person has recommended Kevin
Join now to viewOther similar profiles
Explore more posts
-
GTL - Greenwolf Tech Labs
Commercial teams, PSPs, and leadership can’t align if they’re not working from the same dataset. A centralized data hub integrates sales, SP, refill, and patient-journey metrics into one view turning reactivity into foresight. https://lnkd.in/g8WUTYxB #specialtypharma #pharma #healthcare #lifesciences
-
Precision AQ
7 in 10 HCPs say they’re more likely to act when data reflects their coverage environment. Access strategy is evolving, and so should our conversations. Today’s reps face more than just formulary hurdles. They’re navigating localized coverage decisions, prior authorizations, and copay dynamics, all while trying to stay relevant to each HCP’s unique patient mix. Generic coverage data no longer cuts it. Reps need to speak to real-world access realities, from prior authorizations to out-of-pocket costs. That’s why Access Genius delivers HCP-level insights that turn data into action. Learn how reps are winning with smarter, more personalized coverage conversations: https://hubs.ly/Q03HtNpQ0 #MarketAccess #PrecisionAQ #AccessStrategy #HCPInsights
-
Danforth Health
AI in clinical development is moving fast — but operational adoption is still catching up. Our latest industry pulse survey reveals where organizations are experimenting with AI, where real value is emerging, and what’s still holding adoption back. Swipe through for 4 key insights. Read the full survey findings here: https://lnkd.in/en7QVXNZ Navigating AI adoption, outsourcing strategy, or governance decisions? Connect with our Clinical Business Operations team for guidance and support: https://lnkd.in/eGufCi4f #ClinicalTrials #AIinHealthcare #LifeSciences #ClinicalOperations #ClinicalContracting #Biotech
-
NCPDP
🤝 NCPDP joins the CMS Health Technology Ecosystem as a Friend of the Network! This milestone shows the importance of pharmacy and medication standards in building a more connected, interoperable health care system. By participating in the CMS Aligned Network, NCPDP will bring pharmacy expertise to national interoperability efforts to help shape guidance, frameworks, and future health IT policies. This collaboration strengthens connections across the ecosystem and supports innovation that enables safer, more timely, and more connected care for patients nationwide. 🔗 Read the full announcement: https://lnkd.in/ezftM7CJ #PharmacyLeadership #Interoperability #HealthTechnology #CMS #HealthIT #ConnectedCare
-
Pharma Focus Asia Magazine
Patient voice is redefining how evidence shapes access, value, and outcomes in healthcare. In this exclusive interview, Dimple Dang, co-founder & director of MarksMan Healthcare, shares how HEOR must evolve from passively capturing insights to actively leading patient-centered evidence strategies. https://lnkd.in/gSr4EXPV From integrating real-world patient voice into early 𝐇𝐄𝐎𝐑 design to leveraging AI, NLP, and patient-generated data responsibly, this conversation highlights how structured, validated patient evidence strengthens regulatory confidence, payer engagement, and long-term value communication. Read how patient-centered HEOR is shaping the future of evidence generation and decision-making: https://lnkd.in/gSr4EXPV #HEOR #PatientCentricity #RealWorldEvidence #HealthEconomics #MarketAccess #PharmaStrategy #ValueBasedHealthcare #PatientVoice #DigitalHealth #OutcomesResearch #LifeSciences #PharmaFocusAsia
2 Comments -
Wheel
📊 What will separate leading DTP pharma virtual care programs in 2026? The answer is already emerging in the data. Wheel is partnering with DHC Group for an upcoming webinar that unpacks early insights from Wheel’s 2026 Virtual Care Data Report that's built on millions of real-world virtual patient visits. In this session, we’ll explore: • Consumer and care delivery trends shaping virtual-first healthcare • What life sciences, digital health, and retail health leaders should be watching now • How proprietary visit-level data can inform smarter commercial and engagement strategies Speakers Chris Moose Ian Essling Elsa Rive Boukadoum If you’re focused on the future of care delivery, patient engagement, or healthcare innovation, this conversation is for you. Register here: https://lnkd.in/gPMSmriA #VirtualCare #HealthcareData #LifeSciences #DigitalHealth #HealthcareInnovation #ThoughtLeadership
-
MiBA
Integrating Data, Diagnostics, and Delivery: The Next Era of Oncology Innovation By Toni Perry, RN, MSN , Vice President of Strategic Partnerships & Innovation at MiBA Analytics The oncology landscape is changing — not just in how we treat cancer, but in how we connect the data, insights, and people who drive every decision that follows. At MiBA Analytics, we’ve seen a clear pattern across our collaborations with community oncology practices, diagnostic innovators, and biopharma partners: the real breakthroughs happen when integration replaces isolation. When stakeholders align around a shared view of the patient journey — from the first test to follow-up therapy — we see measurable impact: • Earlier biomarker identification, leading to more patients receiving targeted therapies. • Reduced delays in testing, closing gaps that often lead to missed clinical trial opportunities. • Connected real-world data and clinical insight, producing stronger evidence to guide both access and value-based decisions. These efforts are bridging discovery and delivery, redefining what innovation looks like in real-world oncology. But meaningful transformation also requires tough conversations: • How can we align incentives so that community practices truly benefit from data-driven care models? • How do we scale equitable access to precision medicine while keeping workflows simple? • How do we measure impact beyond revenue — toward patient outcomes and system value? At MiBA, we believe the answers will come not from any single company, but from a network willing to evolve together — one that unites the power of data with the purpose of improving lives. If your organization shares this vision and is working to advance value-based oncology, precision medicine adoption, or data-driven collaboration, we’d welcome the opportunity to connect and explore partnership opportunities. 📩 Contact us at info@mibaanalytics.com, or toni.perry@mibanalytics.com, or visit www.mibaanalytics.com to learn more about how we’re helping bridge data to decisions in oncology.
1 Comment
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Kevin Clayton
216 others named Kevin Clayton are on LinkedIn
See others named Kevin Clayton